Equities Analysts Offer Predictions for ALNY Q1 Earnings
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) – Investment analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for shares of Alnylam Pharmaceuticals in a report issued on Monday, February 24th. HC Wainwright analyst P. Trucchio expects that the biopharmaceutical company will post earnings of ($1.00) per share for the quarter. […]
